A Outcomes of Vancomycin Enema vs Normal Saline Enema in Patients with Hirschsprung’s Associated Enterocolitis

Authors

  • Muhammad Rehan Northwest General Hospital and Research Center Peshawar
  • Saman Gul Naseer Teaching Hospital Peshawar
  • Muhammad Salman Saleem Department of Pediatric Surgery Children Hospital Lahore
  • Nasim Khan Department of Pediatric Surgeon Lady Ready Hospital Peshawar
  • Khawar Saeed Northwest General Hospital and Research Center Peshawar

DOI:

https://doi.org/10.35845/abms.2024.2.351

Keywords:

Hirschsprung’s disease, Enterocolitis, Vancomycin, Normal Saline Enema

Abstract

OBJECTIVE: This research was designed to compare the outcomes of vancomycin enema and normal saline enema in the treatment of HAEC in terms of full remission of symptoms of HAEC and length of hospital stay.

METHODOLOGY: This randomized controlled trial was carried out from March 2020 to March 2021 in the Department of Pediatric Surgery at Lady Reading Hospital Peshawar. A total of 40 patients were randomly assigned in two groups; A (vancomycin enema) and B (normal saline enema), with 20 patients in each group. After the diagnosis was established, patients were randomly assigned to one of two groups by balloting method. SPSS 24 was used for data entry and analysis

RESULTS: In our research, males outnumbered females. In both groups, the HAEC score decreased significantly after treatment from pre-treatment scores (12.31 and 11.15) to post-treatment scores (7.73 and 7.61) with significant p --values 0.013 & 0.015 respectively. The average hospital stay between vancomycin enema and normal saline enema group was 7.91 days as opposed to 6.89 days with a p-value (0.031). Overall, 7.33 ± 2.426 days were required for full remission of HAEC symptoms in the study. A p-value of 0.251 suggested that there was no difference between groups in terms of symptom relief

CONCLUSION: We conclude that there is no difference between the normal saline and vancomycin enema in terms of symptom resolution and hospital stay in patients of HAEC.

References

Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. InSeminars in pediatric surgery 2012 Nov 1 (Vol. 21, No. 4, pp. 328-335). WB Saunders.

Demehri FR, Halaweish IF, Coran AG, Teitelbaum DH. Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention. Pediatric surgery international. 2013 Sep;29:873-81.

Roorda D, Oosterlaan J, van Heurn E, Derikx JP. Risk factors for enterocolitis in patients with Hirschsprung disease: a retrospective observational study. Journal of Pediatric Surgery. 2021 Oct 1;56(10):1791-8.

Dore M, Sanchez AV, Junco PT, Barrena S, De Ceano-Vivas M, Gomez JJ, Moreno AM, Santamaria ML, Martinez L. Reliability of the Hirschsprung-associated enterocolitis score in clinical practice. European Journal of Pediatric Surgery. 2019 Feb;29(01):132-7.

Pastor AC, Osman F, Teitelbaum DH, Caty MG, Langer JC. Development of a standardized definition for Hirschsprung-associated enterocolitis: a Delphi analysis. Journal of pediatric surgery. 2009 Jan 1;44(1):251-6.

Lane VA, Sugarman ID. Investigation of rectal bleeding in children. Paediatrics and Child Health. 2010 Oct 1;20(10):465-72.

Estevão-Costa J, Fragoso AC, Carvalho JL. Inpatient management of Hirschsprung’s associated enterocolitis treatment: the benefits of standardized care (Svetanoff WJ et al., Pediatr Surg Int (2020) 26: 1413–1421). Pediatric Surgery International. 2021 Apr;37:525-.

Ahmed Mohamed Abd El-Lattif H, Mohamed Mohamed Ismail M, Hamed Gouda S. Study of the effect of lactobacillus acid fast as a prophylaxis for enter-colitis following surgery for hirschsprung’s disease in children. Al-Azhar Medical Journal. 2021 Apr 1;50(2):863-74.

Vieten D, Spicer R. Enterocolitis complicating Hirschsprung’s disease. InSeminars in Pediatric Surgery 2004 Nov 1 (Vol. 13, No. 4, pp. 263-272). WB Saunders.

Noviello C, Cobellis G, Romano M, Amici G, Martino A. Diagnosis of Hirschsprung’s Disease: an age‐related approach in children below or above one year. Colorectal Disease. 2010 Oct;12(10):1044-8.

Gosain A, Frykman PK, Cowles RA, Horton J, Levitt M, Rothstein DH, Langer JC, Goldstein AM, American Pediatric Surgical Association Hirschsprung Disease Interest Group. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatric surgery international. 2017 May;33:517-21.

Guillaume AW, Miller AC, Nguyen MC. Enterocolitis in a child with Hirschsprung disease. Pediatric emergency care. 2019 Jul 1;35(7):e131-2.

Marty TL, Seo T, Sullivan JJ, Matlak ME, Black RE, Johnson DG. Rectal irrigations for the prevention of postoperative enterocolitis in Hirschsprung's disease. Journal of pediatric surgery. 1995 May 1;30(5):652-4.

Shetler K, Nieuwenhuis R, Wren SM, Triadafilopoulos G. Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis. Surgical endoscopy. 2001 Jul;15:653-9.

Kim PK, Huh HC, Cohen HW, Feinberg EJ, Ahmad S, Coyle C, Teperman S, Boothe H. Intracolonic vancomycin for severe Clostridium difficile colitis. Surgical Infections. 2013 Dec 1;14(6):532-9.

Parahita IG, Makhmudi A. Comparison of Hirschsprung-associated enterocolitis following Soave and Duhamel procedures. Journal of pediatric surgery. 2018 Jul 1;53(7):1351-4.

Published

2025-01-01

How to Cite

1.
Rehan M, Gul S, Saleem MS, Khan N, Saeed K. A Outcomes of Vancomycin Enema vs Normal Saline Enema in Patients with Hirschsprung’s Associated Enterocolitis . Adv Basic Med Sci [Internet]. 2025Jan.1 [cited 2025Jan.6];8(2). Available from: https://abms.kmu.edu.pk/index.php/abms/article/view/351